Journey Medical Corp (DERM)
3.51
-0.02
(-0.57%)
USD |
NASDAQ |
May 10, 16:00
3.54
+0.03
(+0.85%)
After-Hours: 20:00
Journey Medical Gross Profit Margin (Quarterly): 60.58% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 60.58% |
September 30, 2023 | 81.39% |
June 30, 2023 | 54.77% |
March 31, 2023 | 47.20% |
December 31, 2022 | 51.66% |
September 30, 2022 | 55.19% |
June 30, 2022 | 58.27% |
March 31, 2022 | 64.79% |
Date | Value |
---|---|
December 31, 2021 | 45.62% |
September 30, 2021 | 43.05% |
June 30, 2021 | 51.05% |
March 31, 2021 | 63.54% |
December 31, 2020 | 68.80% |
September 30, 2020 | 64.23% |
June 30, 2020 | 66.82% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
43.05%
Minimum
Sep 2021
81.39%
Maximum
Sep 2023
58.46%
Average
58.27%
Median
Jun 2022
Gross Profit Margin (Quarterly) Benchmarks
Fortress Biotech Inc | 69.84% |
GT Biopharma Inc | -- |
FibroGen Inc | 53.93% |
Outlook Therapeutics Inc | -- |
ABVC BioPharma Inc | -6.33K% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -30.97% |
Return on Assets | -4.66% |
Return on Invested Capital | -14.55% |
Profit Margin (Quarterly) | -14.05% |
Operating Margin (Quarterly) | -13.79% |
Return on Net Operating Assets | -7.03% |